J&J’s RYBREVANT Shows Longest OS in EGFR Lung Cancer
Raritan, New Jersey, U.S., September 14, 2026 Johnson & Johnson announced new overall survival data from the Phase III...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Raritan, New Jersey, U.S., September 14, 2026 Johnson & Johnson announced new overall survival data from the Phase III...
San Diego, California, U.S., September 14, 2026 AbelZeta Therapeutics has announced that the U.S. Food and Drug Administration (FDA)...
Taipei, Taiwan, September 11, 2026 Avance Clinical has received the Australia-Taiwan Business Excellence Award from the Australia New Zealand...
Burlington, North Carolina, USA, September 8, 2026 Labcorp has acquired MLM Medical Labs, strengthening its global central laboratory and...
Abbott Park, Illinois, U.S., September 8, 2026 Abbott has received U.S. FDA approval for its TactiFlexâ„¢ Duo Ablation Catheter,...
Titusville, New Jersey, U.S., September 8, 2026 Johnson & Johnson is set to present new clinical and real-world evidence...
Hong Kong, September 8, 2026 Ascletis Pharma Inc. has announced the initiation of a U.S. Phase 1 clinical trial...
SAN ANTONIO — September 8, 2026 PT Prodia Diacro Laboratories (Prodia the CRO) has received Frost & Sullivan’s 2026...
Fremont, California, USA — September 3, 2026 Cytek Biosciences, Inc. announced that it will showcase its spectral flow cytometry...
Research Triangle Park, North Carolina — September 3, 2026 IQVIA announced the launch of IQVIA Predictive Clinical Development, an...
